Multi-biomarker risk stratification to identify patients with coronary artery disease at high risk for subsequent cardiac adverse events

被引:0
|
作者
Mueller, C. [1 ]
Giurgea, G. -A. [1 ]
Zlabinger, K. [1 ]
Karpat, I. [1 ]
Gugerell, A. [1 ]
Lukovic, D. [1 ]
Syeda, B. [1 ]
Mandic, L. [1 ]
Pavo, N. [1 ]
Bergler-Klein, J. [1 ]
Gyoengyoesi, M. [1 ]
机构
[1] Med Univ Vienna, Dept Internal Med 2, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
18-3
引用
收藏
页码:110 / 110
页数:1
相关论文
共 50 条
  • [31] Pathophysiology, risk stratification, and management of sudden cardiac death in coronary artery disease
    El-Sherif, Nabil
    Khan, Abdullah
    Savarese, Joseph
    Turitto, Gioia
    CARDIOLOGY JOURNAL, 2010, 17 (01) : 4 - 10
  • [32] Sudden Cardiac Death and Coronary Artery Disease-Pathophysiology and Risk Stratification
    El-Sherif, Nabil
    Khan, Abdullah
    Savarese, Joseph
    Turitto, Gioia
    JOURNAL OF ARRHYTHMIA, 2009, 25 (03) : 122 - 129
  • [33] The Genetic Risk Score with Variants in PDGFs and PDGFRB for the Risk of Major Cardiovascular Adverse Events in Patients with Coronary Artery Disease
    Xu, Xiaojuan
    Li, Wen
    Liu, Fangyuan
    Chen, Changying
    Xie, Hankun
    Wang, Feifan
    Han, Xu
    Zhuang, Qian
    Zhao, Xianghai
    Sun, Junxiang
    Yin, Yunjie
    Wei, Pengfei
    Chen, Yanchun
    Yang, Song
    Shen, Chong
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2025,
  • [34] Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with cardiac sarcoidosis
    Yasuda, Masakazu
    Iwanaga, Yoshitaka
    Kato, Takao
    Izumi, Toshiaki
    Inuzuka, Yasutaka
    Nakamura, Takashi
    Miyaji, Yuki
    Kawamura, Takayuki
    Ikeguchi, Shigeru
    Inoko, Moriaki
    Kurita, Takashi
    Miyazaki, Shunichi
    OPEN HEART, 2016, 3 (02):
  • [35] RADIONUCLIDE ANGIOGRAPHY FOR RISK STRATIFICATION OF PATIENTS WITH CORONARY-ARTERY DISEASE
    BONOW, RO
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (09): : 735 - 739
  • [36] Stratification of symptomatic patients with low to intermediate risk of coronary artery disease
    Winther, S.
    Nissen, L.
    Westra, J.
    Frost, L.
    Urbonaviciene, G.
    Holm, N. R.
    Christiansen, E. H.
    Botker, H. E.
    Bottcher, M.
    EUROPEAN HEART JOURNAL, 2017, 38 : 189 - 189
  • [37] Renovascular disease and the risk of adverse cardiac events
    Edwards, MS
    Craven, TE
    Burke, GL
    Dean, RH
    Hansen, KJ
    CIRCULATION, 2003, 108 (17) : 633 - 634
  • [38] A Multi-Biomarker Approach to Increase the Accuracy of Diagnosis and Management of Coronary Artery Disease
    Hostacna, Lenka
    Maslankova, Jana
    Pella, Dominik
    Hubkova, Beata
    Marekova, Maria
    Pella, Daniel
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (09)
  • [39] Serum Uric Acid for Risk Stratification of Patients with Coronary Artery Disease
    Brodov, Yafim
    Chouraqui, Pierre
    Goldenberg, Ilan
    Boyko, Valentina
    Mandelzweig, Lori
    Behar, Shlomo
    CARDIOLOGY, 2009, 114 (04) : 300 - 305
  • [40] Is There a Role for Further Risk Stratification of Patients With Stable Coronary Artery Disease?
    O'Malley, Patrick G.
    JAMA INTERNAL MEDICINE, 2013, 173 (09) : 770 - 770